{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:02:45Z","timestamp":1768791765997,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.07.062","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T08:33:03Z","timestamp":1218616383000},"page":"5494-5502","source":"Crossref","is-referenced-by-count":36,"title":["A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge"],"prefix":"10.1016","volume":"26","author":[{"given":"S.D.","family":"Klas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Warwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Olds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Stenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Cheff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hinchcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2008.07.062_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archinte.158.5.429","article-title":"Anthrax as a potential biological warfare agent","volume":"158","author":"Pile","year":"1998","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.062_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.07.062_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0264-410X(98)00023-1","article-title":"The effectiveness and safety of vaccines against human anthrax: a systematic review","volume":"16","author":"Demicheli","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2672.1999.00896.x","article-title":"Clinical aspects, diagnosis and treatment of anthrax","volume":"87","author":"Friedlander","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","article-title":"Anthrax: the disease in relation to vaccines","volume":"2","author":"Hambleton","year":"1984","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.062_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.07.062_bib7","series-title":"The anthrax vaccine. Is it safe? Does it work?","author":"Institute of Medicine","year":"2002"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.062_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/hv.3.3.4011","article-title":"Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge","volume":"3","author":"Huang","year":"2007","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.062_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jps.20484","article-title":"Anthrax vaccine powder formulations for nasal mucosal delivery","volume":"95","author":"Jiang","year":"2006","journal-title":"J Pharma Sci"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.07.062_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2008.07.062_bib12","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2006.02.024","article-title":"An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits","volume":"24","author":"Wimer-Mackin","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.07.062_bib13","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine","volume":"24","author":"Little","year":"2006","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2008.07.062_bib14","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly(gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.062_bib15","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"10.1016\/j.vaccine.2008.07.062_bib16","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.vaccine.2006.12.043","article-title":"Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine","volume":"25","author":"Little","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.062_bib17","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.07.062_bib18","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.07.062_bib19","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.062_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1211\/jpp.58.4.0003","article-title":"Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice","volume":"58","author":"Sloat","year":"2006","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","article-title":"Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization","volume":"70","author":"Kobiler","year":"2002","journal-title":"Infect Immun"},{"issue":"5188","key":"10.1016\/j.vaccine.2008.07.062_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.062_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3201\/eid0810.020331","article-title":"Adherence to antimicrobial inhalation anthrax prophylaxis among postal workers, Washington D.C., 2001","volume":"8","author":"Jefferds","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.062_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib26","first-page":"97","article-title":"A single dose vaccine to prevent neonatal tetnus","volume":"41","author":"Dastur","year":"1993","journal-title":"J Assoc Phys India"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.062_bib27","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against Whooping cough","volume":"2","author":"Miecarek","year":"2006","journal-title":"PLos Pathogens"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.062_bib28","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies","volume":"74","author":"Schlereth","year":"2000","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.062_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2008.07.062_bib30","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0264-410X(98)00438-1","article-title":"Dry powder inhalation as a potential delivery method for vaccines","volume":"17","author":"LiCalsi","year":"1999","journal-title":"Vaccine"},{"issue":"98","key":"10.1016\/j.vaccine.2008.07.062_bib31","first-page":"33","article-title":"Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans","author":"Mestecky","year":"1997","journal-title":"Behring Inst Mitt"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.062_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.3.1.87","article-title":"Noninvasive delivery technologies: respiratory delivery of vaccines","volume":"3","author":"Sullivan","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/17425247.3.2.247","article-title":"Intranasal delivery of vaccines against HIV","volume":"3","author":"Vajdy","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.062_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/513980","article-title":"Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae","volume":"175","author":"Wu","year":"1997","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.062_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1399-302X.2003.00067.x","article-title":"Intranasal immunization of humans with Streptococcus mutans antigens","volume":"18","author":"Li","year":"2003","journal-title":"Oral Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.062_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","article-title":"Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan","volume":"22","author":"McNeela","year":"2004","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.07.062_bib37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0264-410X(02)00481-4","article-title":"Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine","volume":"21","author":"Muszkat","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.062_bib38","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.062_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1574-695X.2007.00280.x","article-title":"A comparison of immunogenicity and protective immunity against experimental plague by intranasal and\/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen","volume":"51","author":"Liu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"28","key":"10.1016\/j.vaccine.2008.07.062_bib40","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.vaccine.2007.04.081","article-title":"A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system","volume":"25","author":"Youn","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.062_bib41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.062_bib42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.062_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2008.07.062_bib44","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0264-410X(99)00572-1","article-title":"Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration","volume":"18","author":"Baldridge","year":"2000","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.07.062_bib45","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1128\/IAI.73.12.8256-8265.2005","volume":"73","author":"Huo","year":"2005","journal-title":"Infection and Immun"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2008.07.062_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.062_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.062_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"Wang","year":"2005","journal-title":"Med Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.062_bib49","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-006-0206-9","article-title":"Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.062_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-8244(03)00366-3","article-title":"Induction of opsonic antibodies to the gamma-d-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate","volume":"40","author":"Wang","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.062_bib51","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/IAI.00315-06","article-title":"Additional conjugation methods and immunogenicity of Bacillus anthracis poly-G-d-glutamic acid-protein conjugates","volume":"74","author":"Kubler-Kielb","year":"2006","journal-title":"Infect Immun"},{"issue":"37","key":"10.1016\/j.vaccine.2008.07.062_bib52","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.07.062_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies in spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb Pathog"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2008.07.062_bib54","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.062_bib55","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol"},{"issue":"32","key":"10.1016\/j.vaccine.2008.07.062_bib56","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.062_bib57","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T14:28:16Z","timestamp":1545834496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08010116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":57,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08010116"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}